key: cord-0983914-yo6u4qkq
authors: Mullan, Clancy; Powierza, Camilla; Miller, P. Elliott; Geirsson, Arnar; Vallabhajosyula, Prashanth; Assi, Roland
title: Spontaneous coronavirus disease 2019 (COVID-19)-associated luminal aortic thrombus
date: 2020-06-09
journal: J Thorac Cardiovasc Surg
DOI: 10.1016/j.jtcvs.2020.05.024
sha: 077148635588618470fe8d8022c1495542705315
doc_id: 983914
cord_uid: yo6u4qkq

nan

To the Editor: Coronavirus disease 2019 (COVID-19) has been associated with profound coagulopathies via direct and indirect mechanisms. 1 Aortic thrombus is typically identified in atherosclerotic or aneurysmal aortas and can be discovered as a rare embolic source. 2 We report 2 cases of aortic intraluminal thrombi without history of aortic disease, vasculitis, or coagulopathy.

Patient 1 was a 62-year-old male patient with hyperlipidemia who presented with diarrhea and hypoxia and was diagnosed with COVID-19 on April 28, 2020. He was supported for 72 hours then progressed to hypoxic respiratory failure requiring mechanical ventilation. His presenting laboratory work was notable for D-dimer of 1.19 mg/L (normal <0.57 mg/L) and fibrinogenemia to 728 mg/dL (normal <464 mg/dL). He was started on 160 mg of subcutaneous enoxaparin daily. His D-dimer increased to 14.87 mg/L at the time of decompensation. An emergent computed tomography (CT) scan with pulmonaryÀarterial-phase contrast was obtained. A large ascending intraluminal thrombus, as well as a distinct proximal descending thoracic aortic intraluminal thrombus, was found with normal aortic size and wall thickness and without calcifications (Figure 1,  A) . No echocardiographic evidence of ventricular thrombus or endocarditis was found. CT of his brain identified a large right parietal stroke. A multidisciplinary team agreed to low-dose heparin infusion, without an antiplatelet agent, and repeat CT angiography in approximately 2 weeks to ensure thrombus dissolution.

Patient 2 was a 57-year-old male patient with diabetes mellitus, hypertension, hyperlipidemia, and previous transient ischemic attack who developed fevers and myalgias and was diagnosed with COVID-19 via reversetranscription polymerase chain reaction Q3 on April 16, 2020. Presentation studies were notable for a normal D-dimer of 0.46 mg/L. His home medications included daily aspirin, which was continued throughout his hospitalization, along with enoxaparin prophylaxis. Shortly thereafter, he was transferred to the intensive care unit for hypoxic respiratory failure requiring noninvasive positive pressure ventilation. On hospital day 9, he developed acute abdominal pain and an elevated lactate of 3.1 mmol/L. His D-dimer peaked at 29.97 mg/L the same day. An emergent CT of his abdomen and pelvis identified bilateral renal infarcts and distal thoracic aortic thrombus, in an otherwiseunremarkable aorta (Figure 1, B) . He was also started on a heparin infusion, which resulted in a return of his distal pulses.

The biologic underpinnings of COVID-19-related coagulopathy are complex, 1 and acute aortic thrombus related to COVID-19 infection has been described only once to

The authors reported no conflicts of interest.

The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.

https://doi.org/10.1016/j.jtcvs.2020.05.024

Letter to the Editor e2

The Journal of Thoracic and Cardiovascular Surgery c -2020 COR 5.6.0 DTD YMTC16247_proof 8 June 2020 6:28 pm ce JM   123  124  125  126  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183   184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204  205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244 

COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up

Aortic mural thrombus in the normal or minimally atherosclerotic aorta

Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia